News

Regeneron Pharmaceuticals will acquire embattled DNA testing company 23andMe in a $256 million court-supervised sale, ...
The sale was for $256 million and is expected to be complete by the third quarter of this year, according to a Regeneron news ...
President Donald Trump is heading to Capitol Hill early Tuesday to seal the deal on his “big, beautiful bill,” using the ...
It’s well documented that AI is a power-hungry technology. But there has been far less reporting on the extent of that hunger ...
Regeneron acquires 23andMe for $256 million following its bankruptcy. The deal includes DNA data access, raising privacy ...